Association study of an epidermal growth factor gene functional polymorphism with the risk and prognosis of gliomas in Brazil

International Journal of Biological Markers

Volumn 24, Issue 4, 2009, Pages 277-281

  Pinto, Giovanny R ^a,b   Yoshioka, France K N ^a   Clara, Carlos A ^c   Santos, Marcelo J ^c   Almeida, José R W ^c   Burbano, Rommel R ^d   Rey, Juan A ^e   Casartelli, Cacilda ^b  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Cancer Hospital of Barretos   (Brazil)

^d FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

EGF; Gliomas; Polymorphism; Prognosis; Risk

Indexed keywords

EPIDERMAL GROWTH FACTOR;

5' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; BRAZIL; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOTYPE; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POPULATION BASED CASE CONTROL STUDY; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 76649112061     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2009.5517     Document Type: Article

References (15)

1. Kleihues P, Cavenee WK (eds). World Health Organization Classification of Tumours. Pathology and genetics of tumours of the nervous system. IARC Press, Lyon 2000.
2. Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995; 19: 183-232.
3. Shahbazi M, Pravica V, Nasreen N, et al. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 2002; 359: 397-401.
4. Jin G, Miao R, Deng Y, et al. Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population. Cancer Sci 2007; 98: 864-8.
5. Lanuti M, Liu G, Goodwin JM, et al. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res 2008; 14: 3216-22.
6. Lim YJ, Kim JW, Song JY, et al. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. Neurosci Lett 2005; 374: 157-60.
7. Kang HG, Choi JE, Lee WK, et al. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer. Respirology 2007; 12: 902-5.
8. Bhowmick DA, Zhuang Z, Wait SD, Weil RJ. A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res 2004; 64: 1220-3.
9. Costa BM, Ferreira P, Costa S, et al. Association between functional EGF+61 polymorphism and glioma risk. Clin Cancer Res 2007; 13: 2621-6.
10. Vauleon E, Auger N, Benouaich-Amiel A, et al. The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet 2007; 172: 33-7.
11. Liu X, Li L, Chen X, et al. No association between EGF +61 A/G polymorphism and increased risk of glioma. Int J Biol Markers 2009; 24: 77-82.
12. Pinto GR, Yoshioka FK, Silva RL, et al. Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymorphisms and the susceptibility to gliomas in individuals from Southeast Brazil. Genet Mol Res 2008; 7: 207-16.
13. Pinto GR, Yoshioka FK, Clara CA, et al. WRN Cys1367Arg SNP is not associated with risk and prognosis of gliomas in Southeast Brazil. J Neurooncol 2008; 90: 253-8.
14. Randerson-Moor JA, Gaut R, Turner F, et al. The relationship between the epidermal growth factor (EGF) 5'UTR variant A61G and melanoma/nevus susceptibility. J Invest Dermatol 2004; 123: 755-9.
15. Okamoto I, Roka F, Krogler J, et al. The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma. J Invest Dermatol 2006; 126: 2242-6.